Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2Phase 2/3 1

Status

Completed 7Terminated 4Active not recruiting 3Unknown 2Withdrawn 1

Sponsor Class

INDUSTRY 6OTHER 1

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 7Gastrointestinal 4Head & Neck 2Tumor-Agnostic 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Small Cell Lung Carcinoma 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × Tiragolumab × Thoracic × Clear all
NCT04513925 2026-06-03

SKYSCRAPER-03

Hoffmann-La Roche

Phase 3 Completed
829 enrolled 40 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04619797 2026-06-03

SKYSCRAPER-06

Hoffmann-La Roche

Phase 2/3 Completed
542 enrolled 28 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03563716 2026-05-04

A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Genentech, Inc.

Phase 2 Completed
135 enrolled 19 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04256421 2026-04-03

SKYSCRAPER-02

Hoffmann-La Roche

Phase 3 Completed
490 enrolled 33 charts
Thoracic

Small Cell Lung Carcinoma

NCT06267001 2026-02-03

SKYSCRAPER-15

Hoffmann-La Roche

Phase 3 Completed
56 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04294810 2026-01-30

SKYSCRAPER-01

Hoffmann-La Roche

Phase 3 Completed
620 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03977467 2025-08-27

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

SCRI Development Innovations, LLC

Phase 2 Completed
46 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡